Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells
ConclusionOur results demonstrate that one can use lysates from allogeneic melanoma cell lines as a source of CTA for DC load during the production of anticancer vaccines for the STBS treatment. Patterns of CTA expression should be evaluated as biomarkers of response in prospective clinical trials.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Genetics | Immunotherapy | Melanoma | Sarcomas | Skin Cancer | Soft Tissue Sarcoma | Vaccines